February 14th, 2025 |
Christophe Arbet-engels |
Chief Medical Officer |
Stock Award
|
850.00K |
$- |
864.21K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
850000 |
$0.00 |
$- |
|
February 14th, 2025 |
Adam Mostafa |
Chief Financial Officer |
Stock Award
|
850.00K |
$- |
850.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
850000 |
$0.00 |
$- |
|
February 14th, 2025 |
Paula Ragan |
Director, Officer: President And CEO |
Stock Award
|
2.25M |
$- |
3.34M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
2250000 |
$0.00 |
$- |
|
February 14th, 2025 |
Mark Baldry |
Chief Commercial Officer |
Stock Award Purchase
|
635.05K |
$19.25K |
729.17K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
600000 |
$0.00 |
$- |
Common Stock |
Purchase
|
13404 |
$0.34 |
$4.60K |
Common Stock |
Purchase
|
21646 |
$0.68 |
$14.65K |
|
February 14th, 2025 |
Mary Dibiase |
Chief Operating Officer |
Stock Award
|
650.00K |
$- |
1.14M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
650000 |
$0.00 |
$- |
|
January 27th, 2025 |
Paula Ragan |
Director, Officer: President And CEO |
Stock Award Sale
|
246.41K |
$34.72K |
1.16M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
169940 |
$0.00 |
$- |
Common Stock |
Sale
|
76473 |
$0.45 |
$34.72K |
|
January 27th, 2025 |
Adam Mostafa |
Chief Financial Officer |
Stock Award Sale
|
149.55K |
$33.95K |
74.77K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
74773 |
$0.00 |
$- |
Common Stock |
Sale
|
74773 |
$0.45 |
$33.95K |
|
January 27th, 2025 |
Mark Baldry |
Chief Commercial Officer |
Stock Award Sale
|
103.93K |
$13.24K |
123.28K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
74773 |
$0.00 |
$- |
Common Stock |
Sale
|
29159 |
$0.45 |
$13.24K |
|
January 27th, 2025 |
Mary Dibiase |
Chief Operating Officer |
Stock Award Sale
|
83.44K |
$10.09K |
513.24K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
61178 |
$0.00 |
$- |
Common Stock |
Sale
|
22258 |
$0.45 |
$10.09K |
|
January 27th, 2025 |
Christophe Arbet-engels |
Chief Medical Officer |
Stock Award Sale
|
37.45K |
$5.28K |
25.83K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
25831 |
$0.00 |
$- |
Common Stock |
Sale
|
11624 |
$0.45 |
$5.28K |
|
November 19th, 2024 |
Paula Ragan |
Director, Officer: President And CEO |
Sale
|
31.90K |
$12.58K |
993.92K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
31897 |
$0.39 |
$12.58K |
|
October 16th, 2024 |
Paula Ragan |
Director, Officer: President And CEO |
Sale
|
31.90K |
$17.93K |
1.03M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
31897 |
$0.56 |
$17.93K |
|
October 8th, 2024 |
Adam Mostafa |
Chief Financial Officer |
Stock Award Sale
|
461.29K |
$126.90K |
230.65K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
230645 |
$0.00 |
$- |
Common Stock |
Sale
|
230645 |
$0.55 |
$126.90K |
|
October 8th, 2024 |
Mark Baldry |
Chief Commercial Officer |
Stock Award Sale
|
46.07K |
$6.51K |
59.64K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
34946 |
$0.00 |
$- |
Common Stock |
Sale
|
11127 |
$0.58 |
$6.51K |
|
October 8th, 2024 |
Paula Ragan |
Director, Officer: President And CEO |
Stock Award Sale
|
771.52K |
$131.52K |
1.30M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
532081 |
$0.00 |
$- |
Common Stock |
Sale
|
239436 |
$0.55 |
$131.52K |
|
October 8th, 2024 |
Mary Dibiase |
Chief Operating Officer |
Stock Award Sale
|
298.34K |
$38.33K |
519.75K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
230645 |
$0.00 |
$- |
Common Stock |
Sale
|
67695 |
$0.57 |
$38.33K |
|
October 8th, 2024 |
Arthur Taveras |
Chief Scientific Officer |
Stock Award Sale
|
307.56K |
$43.31K |
464.95K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
230645 |
$0.00 |
$- |
Common Stock |
Sale
|
76920 |
$0.56 |
$43.31K |
|
September 11th, 2024 |
Mary Dibiase |
Chief Operating Officer |
Sale
|
2.64K |
$1.74K |
289.11K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
2642 |
$0.66 |
$1.74K |
|
June 11th, 2024 |
Craecker De |
Director |
Stock Award
|
45.00K |
$- |
96.67K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
45000 |
$0.00 |
$- |
|
June 11th, 2024 |
William Aliski |
Director |
Stock Award
|
45.00K |
$- |
96.67K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
45000 |
$0.00 |
$- |
|
June 11th, 2024 |
David Mcgirr |
Director |
Stock Award
|
45.00K |
$- |
96.67K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
45000 |
$0.00 |
$- |
|
June 11th, 2024 |
Murray Stewart |
Director |
Stock Award
|
45.00K |
$- |
191.50K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
45000 |
$0.00 |
$- |
|
June 11th, 2024 |
Gary Bridger |
Director |
Stock Award
|
45.00K |
$- |
96.67K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
45000 |
$0.00 |
$- |
|
June 11th, 2024 |
Keith Woods |
Director |
Stock Award
|
45.00K |
$- |
135.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
45000 |
$0.00 |
$- |
|
June 11th, 2024 |
Alison Lawton |
Director |
Stock Award
|
45.00K |
$- |
96.67K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
45000 |
$0.00 |
$- |
|
June 11th, 2024 |
Michael Wyzga |
Director |
Stock Award
|
45.00K |
$- |
121.67K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
45000 |
$0.00 |
$- |
|
March 11th, 2024 |
Arthur Taveras |
Chief Scientific Officer |
Sale
|
14.23K |
$12.55K |
234.30K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
14235 |
$0.88 |
$12.55K |
|
March 11th, 2024 |
Paula Ragan |
Director, Officer: President And CEO |
Sale
|
49.68K |
$43.86K |
765.07K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
49678 |
$0.88 |
$43.86K |
|
March 11th, 2024 |
Adam Mostafa |
Chief Financial Officer |
Sale
|
52.50K |
$46.35K |
- |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
52500 |
$0.88 |
$46.35K |
|
March 11th, 2024 |
Mary Dibiase |
Chief Operating Officer |
Sale
|
15.41K |
$13.59K |
291.75K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
15409 |
$0.88 |
$13.59K |
|
February 28th, 2024 |
Christophe Arbet-engels |
Chief Medical Officer |
Stock Award
|
180.82K |
$166.53K |
180.82K |
Form 4/A
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Appreciation Right |
Stock Award
|
180816 |
$0.92 |
$166.53K |
|
February 16th, 2024 |
Christophe Arbet-engels |
Chief Medical Officer |
Stock Award
|
475.83K |
$438.24K |
475.83K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Appreciation Right |
Stock Award
|
475831 |
$0.92 |
$438.24K |
|
February 16th, 2024 |
Adam Mostafa |
Chief Financial Officer |
Stock Award
|
523.41K |
$482.06K |
523.41K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Appreciation Right |
Stock Award
|
523414 |
$0.92 |
$482.06K |
|
February 16th, 2024 |
Mary Dibiase |
Chief Operating Officer |
Stock Award
|
428.25K |
$394.42K |
428.25K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Appreciation Right |
Stock Award
|
428248 |
$0.92 |
$394.42K |
|
February 16th, 2024 |
Paula Ragan |
Director, Officer: President And CEO |
Stock Award
|
1.19M |
$1.10M |
1.19M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Appreciation Right |
Stock Award
|
1189578 |
$0.92 |
$1.10M |
|
February 16th, 2024 |
Mark Baldry |
Chief Commercial Officer |
Stock Award
|
523.41K |
$482.06K |
523.41K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Appreciation Right |
Stock Award
|
523414 |
$0.92 |
$482.06K |
|
February 16th, 2024 |
Arthur Taveras |
Chief Scientific Officer |
Stock Award
|
428.25K |
$394.42K |
428.25K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Appreciation Right |
Stock Award
|
428248 |
$0.92 |
$394.42K |
|
February 12th, 2024 |
Mary Dibiase |
Chief Operating Officer |
Sale
|
3.68K |
$3.71K |
307.16K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
3683 |
$1.01 |
$3.71K |
|
February 12th, 2024 |
Arthur Taveras |
Chief Scientific Officer |
Sale
|
787 |
$793 |
248.54K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
787 |
$1.01 |
$793 |
|
February 12th, 2024 |
Paula Ragan |
Director, Officer: President And CEO |
Sale
|
21.70K |
$21.89K |
814.75K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
21695 |
$1.01 |
$21.89K |
|
February 12th, 2024 |
Adam Mostafa |
Chief Financial Officer |
Sale
|
27.72K |
$27.97K |
52.50K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
27721 |
$1.01 |
$27.97K |
|
November 3rd, 2023 |
Paula Ragan |
Director, Officer: President And CEO |
Sale
|
239.44K |
$181.57K |
876.35K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
199531 |
$0.73 |
$145.66K |
Common Stock |
Sale
|
39906 |
$0.90 |
$35.92K |
|
November 3rd, 2023 |
Adam Mostafa |
Chief Financial Officer |
Sale
|
230.65K |
$168.37K |
80.22K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
230645 |
$0.73 |
$168.37K |
|
November 3rd, 2023 |
Mary Dibiase |
Chief Operating Officer |
Sale
|
67.69K |
$49.42K |
310.84K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
67695 |
$0.73 |
$49.42K |
|
November 3rd, 2023 |
Mark Baldry |
Chief Commercial Officer |
Sale
|
10.26K |
$7.49K |
24.69K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
10257 |
$0.73 |
$7.49K |
|
November 3rd, 2023 |
Arthur Taveras |
Chief Scientific Officer |
Sale
|
67.69K |
$49.42K |
249.32K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
67695 |
$0.73 |
$49.42K |
|
November 2nd, 2023 |
Adam Mostafa |
Chief Financial Officer |
Stock Award
|
230.65K |
$- |
310.87K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
230645 |
$0.00 |
$- |
|
November 2nd, 2023 |
Mark Baldry |
Chief Commercial Officer |
Stock Award
|
34.95K |
$- |
34.95K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
34947 |
$0.00 |
$- |
|
November 2nd, 2023 |
Arthur Taveras |
Chief Scientific Officer |
Stock Award
|
230.65K |
$- |
317.02K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
230645 |
$0.00 |
$- |
|
November 2nd, 2023 |
Paula Ragan |
Director, Officer: President And CEO |
Stock Award
|
532.08K |
$- |
1.08M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
532081 |
$0.00 |
$- |
|
November 2nd, 2023 |
Mary Dibiase |
Chief Operating Officer |
Stock Award
|
230.65K |
$- |
378.54K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
230645 |
$0.00 |
$- |
|
October 18th, 2023 |
Keith Woods |
Director |
Stock Award
|
90.00K |
$- |
90.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
90000 |
$0.00 |
$- |
|
October 18th, 2023 |
Keith Woods |
|
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
September 12th, 2023 |
Mary Dibiase |
Chief Operating Officer |
Sale
|
2.64K |
$3.30K |
147.89K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
2642 |
$1.25 |
$3.30K |
|
September 5th, 2023 |
Christophe Arbet-engels |
Chief Medical Officer |
Stock Award
|
1.25M |
$1.60M |
1.25M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
1250000 |
$1.28 |
$1.60M |
|
August 22nd, 2023 |
Michael Wyzga |
Director |
Purchase
|
25.00K |
$29.88K |
76.67K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Purchase
|
25000 |
$1.20 |
$29.88K |
|
August 16th, 2023 |
Christophe Arbet-engels |
Officer |
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
August 11th, 2023 |
Murray Stewart |
Director, Officer: Interim Chief Medical Officer |
Stock Award Sale
|
399.95K |
$137.86K |
276.56K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
269893 |
$0.00 |
$- |
Common Stock |
Sale
|
130056 |
$1.06 |
$137.86K |
|
July 5th, 2023 |
Mary Dibiase |
Chief Operating Officer |
Sale
|
464 |
$877 |
150.54K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
464 |
$1.89 |
$877 |
|
July 5th, 2023 |
Adam Mostafa |
Chief Financial Officer |
Sale
|
2.64K |
$4.99K |
80.22K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
2641 |
$1.89 |
$4.99K |
|
June 26th, 2023 |
Mary Dibiase |
Chief Operating Officer |
Sale
|
857 |
$1.65K |
151.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
857 |
$1.93 |
$1.65K |
|
June 26th, 2023 |
Adam Mostafa |
Chief Financial Officer |
Sale
|
5.42K |
$10.45K |
82.86K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
5417 |
$1.93 |
$10.45K |
|
June 26th, 2023 |
Paula Ragan |
Director, Officer: President And CEO |
Sale
|
6.72K |
$12.91K |
543.80K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
6724 |
$1.92 |
$12.91K |
|
June 16th, 2023 |
Mary Dibiase |
Chief Operating Officer |
Sale
|
857 |
$1.91K |
151.86K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
857 |
$2.23 |
$1.91K |
|
June 16th, 2023 |
Adam Mostafa |
Chief Financial Officer |
Sale
|
5.42K |
$12.03K |
88.28K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
5417 |
$2.22 |
$12.03K |
|
June 16th, 2023 |
Paula Ragan |
Director, Officer: President And CEO |
Sale
|
6.72K |
$14.99K |
550.52K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
6724 |
$2.23 |
$14.99K |
|
June 14th, 2023 |
William Aliski |
Director |
Stock Award
|
45.00K |
$- |
51.67K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
45000 |
$0.00 |
$- |
|
June 14th, 2023 |
Gary Bridger |
Director |
Stock Award
|
45.00K |
$- |
51.67K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
45000 |
$0.00 |
$- |
|
June 14th, 2023 |
David Mcgirr |
Director |
Stock Award
|
45.00K |
$- |
51.67K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
45000 |
$0.00 |
$- |
|
June 14th, 2023 |
Michael Wyzga |
Director |
Stock Award
|
45.00K |
$- |
51.67K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
45000 |
$0.00 |
$- |
|
June 14th, 2023 |
Craecker De |
Director |
Stock Award
|
45.00K |
$- |
51.67K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
45000 |
$0.00 |
$- |
|
June 14th, 2023 |
Alison Lawton |
Director |
Stock Award
|
45.00K |
$- |
51.67K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
45000 |
$0.00 |
$- |
|
May 31st, 2023 |
Paula Ragan |
Director, Officer: President And CEO |
Sale
|
6.29K |
$12.27K |
557.25K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
6292 |
$1.95 |
$12.27K |
|
March 13th, 2023 |
Mary Dibiase |
Chief Operating Officer |
Sale
|
18.19K |
$15.28K |
152.71K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
18192 |
$0.84 |
$15.28K |
|
March 13th, 2023 |
Adam Mostafa |
Chief Financial Officer |
Sale
|
52.50K |
$44.10K |
93.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
52500 |
$0.84 |
$44.10K |
|
March 13th, 2023 |
Arthur Taveras |
Chief Scientific Officer |
Sale
|
16.81K |
$14.12K |
86.37K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
16806 |
$0.84 |
$14.12K |
|
March 13th, 2023 |
Paula Ragan |
Director, Officer: President And CEO |
Sale
|
49.68K |
$41.73K |
563.54K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
49678 |
$0.84 |
$41.73K |
|
February 15th, 2023 |
Arthur Taveras |
Chief Scientific Officer |
Sale
|
928 |
$863 |
103.18K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
928 |
$0.93 |
$863 |
|
February 15th, 2023 |
Mary Dibiase |
Chief Operating Officer |
Sale
|
4.35K |
$4.04K |
170.91K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
4348 |
$0.93 |
$4.04K |
|
February 15th, 2023 |
Adam Mostafa |
Chief Financial Officer |
Sale
|
27.72K |
$25.78K |
146.20K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
27721 |
$0.93 |
$25.78K |
|
February 15th, 2023 |
Paula Ragan |
Director, Officer: President And CEO |
Sale
|
21.70K |
$20.18K |
613.22K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
21695 |
$0.93 |
$20.18K |
|
November 9th, 2022 |
Mary Dibiase |
Chief Operating Officer |
Stock Award
|
1.35M |
$- |
1.35M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Appreciation Right |
Stock Award
|
1350000 |
$0.00 |
$- |
|
November 9th, 2022 |
Adam Mostafa |
Chief Financial Officer |
Stock Award
|
1.35M |
$- |
1.35M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Appreciation Right |
Stock Award
|
1350000 |
$0.00 |
$- |
|
November 9th, 2022 |
Arthur Taveras |
Chief Scientific Officer |
Stock Award
|
1.00M |
$- |
1.00M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Appreciation Right |
Stock Award
|
1000000 |
$0.00 |
$- |
|
November 9th, 2022 |
Paula Ragan |
President And CEO |
Stock Award
|
3.44M |
$- |
3.44M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Appreciation Right |
Stock Award
|
3438335 |
$0.00 |
$- |
|
November 4th, 2022 |
Mark Baldry |
Chief Commercial Officer |
Stock Award
|
341.00K |
$644.49K |
341.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
341000 |
$1.89 |
$644.49K |
|